Sourcing high-purity reagents for cellular and preclinical investigation requires strict analytical standards and lot-to-lot consistency. Qualified research facilities seeking to bestellen follistatine peptide can secure verified, laboratory-grade compounds manufactured in US-based facilities to support rigorously controlled in vitro and in vivo studies.
Sourcing high-purity reagents for cellular and preclinical investigation requires strict analytical standards and lot-to-lot consistency. Qualified research facilities seeking to bestellen follistatine peptide can secure verified, laboratory-grade compounds manufactured in US-based facilities to support rigorously controlled in vitro and in vivo studies.
Researchers seeking to bestellen follistatine peptide for qualified laboratory investigations must ensure the compound is obtained from suppliers providing rigorous analytical verification. High-purity Follistatin is supplied exclusively as a research-grade peptide for in vitro assaying, receptor binding studies, and cellular pathway analysis. Institutional procurement requires verifying manufacturer documentation, including lot-specific mass spectrometry (MS) and high-performance liquid chromatography (HPLC) testing.
When evaluating options to purchase or bestellen follistatine peptide for laboratory environments, researchers should prioritize suppliers operating under strict quality systems. PX1 Research delivers analytical-grade compounds synthesized in US-based, GMP-compliant facilities. Every batch undergoes comprehensive testing at an ISO 17025 accredited laboratory, guaranteeing that researchers receive reliable, identity-verified reagents free from heavy metals, residual solvents, or unexpected peptide fragments.
Follistatin is a monomeric autocrine glycoprotein expressed across diverse tissue types, recognized primarily for its high-affinity binding to members of the transforming growth factor-beta (TGF-β) superfamily. In laboratory literature, Follistatin is frequently studied in multiple alternative splicing isoforms, most notably Follistatin-288, Follistatin-300, and Follistatin-344. The precursor protein undergoes differential processing, resulting in distinct tissue distribution, heparin-binding capacities, and operational half-lives in experimental models.
To explore specific structural variants, researchers can view the Follistatin 344 product page for detailed physical specifications. The 344-amino-acid isoform acts as a precursor that circulates in preclinical models, undergoing C-terminal cleavage to generate functional systemic variants. Understanding these structural distinctions is crucial when designing cell culture assays or animal model studies evaluating localized versus systemic protein interactions.
The primary mechanism of action characterized in preclinical literature is Follistatin's potent, bivalent neutralization of activin A and activin B. By binding activin with picomolar affinity, Follistatin physically blocks activin from engaging activin type II receptors (ActRIIA and ActRIIB). In vitro data indicate that this binding event prevents downstream intracellular signaling cascades, specifically suppressing the phosphorylation of Smad2 and Smad3 transcription factors.
In addition to activin inhibition, Follistatin exhibits significant affinity for growth differentiation factor-8 (GDF-8, commonly known as myostatin) and GDF-11. Preclinical studies suggest that by sequestering GDF-8, Follistatin downregulates negative regulators of muscle tissue growth. Researchers evaluating TGF-β signaling pathways often compare these dynamics against broader pathways in our comprehensive research library hub to contextualize downstream cellular responses.
In animal models, particularly rodent models of muscular atrophy and tissue injury, administration of Follistatin constructs has demonstrated pronounced impacts on satellite cell proliferation and skeletal muscle hypertrophy. In vitro assays using primary myoblast cultures show increased expression of myogenin and MyoD following Follistatin exposure, signaling enhanced myogenic differentiation.
Furthermore, preclinical studies suggest that Follistatin's dual antagonism of myostatin and activin reduces fibrotic tissue accumulation in damaged skeletal and cardiac tissues. By preventing Smad-mediated activation of pro-fibrotic gene programs, researchers observe diminished collagen deposition in experimental models of tissue repair. These findings make Follistatin a primary candidate for in vitro research investigating metabolic regulation, muscular dystrophies, and regenerative medicine pathways.
When preparing to bestellen follistatine peptide, verifying chemical identity and purity is paramount to experimental reproducibility. Low-quality recombinant proteins or synthetic peptides often contain truncated sequences, aggregate forms, or high levels of bacterial endotoxins that invalidate cell culture assays by triggering non-specific inflammatory signaling.
PX1 Research ensures that every lot of Follistatin meets rigorous analytical benchmarks prior to distribution:
• Reverse-Phase HPLC (RP-HPLC): Confirms peptide purity exceeding 98%, ensuring the absence of process-related impurities or degraded peptide fragments.
• Electrospray Ionization Mass Spectrometry (ESI-MS): Verifies exact molecular weight and amino acid sequence fidelity against theoretical values.
• Endotoxin Testing (LAL Assay): Ensures bacterial endotoxin levels remain strictly below < 0.01 EU/mg, protecting delicate primary cell lines from endotoxin-induced cytotoxicity.
• Lot Traceability: Complete batch documentation and lot-specific Certificates of Analysis (COAs) are accessible directly through our platform for full transparency.
Within preclinical research focused on tissue growth, repair, and metabolic signaling, Follistatin is frequently studied alongside or compared against other peptide compounds targeting distinct cellular receptors. Understanding how Follistatin compares to other reagents in our catalog helps researchers select the appropriate compound for their specific experimental model.
While Follistatin functions primarily via direct ligand sequestration within the TGF-β superfamily, signaling modulators like IGF-1 LR3 promote cellular proliferation through receptor tyrosine kinase activation (IGF-1R) and Akt/mTOR phosphorylation. In contrast, secretagogues such as CJC-1295 No DAC influence systemic growth factor release by stimulating pituitary growth hormone secretion. For extracellular matrix repair models, researchers often evaluate Follistatin alongside cytoprotective agents like BPC-157. To review our full catalog of research-grade signaling peptides, explore our all peptides directory.
Proper reconstitution is essential to preserve the biological activity of lyophilized Follistatin peptides and prevent premature aggregation or degradation in laboratory solutions. Reconstitution should always be performed inside a certified laminar flow hood using sterile laboratory technique.
1. Centrifugation: Prior to opening the vial, centrifuge the dry lyophilized powder at low speed (1,000–3,000 x g) for 30 seconds to gather all material at the bottom of the vial.
2. Solvent Selection: Reconstitute using sterile bacteriostatic water, sterile 0.9% sodium chloride, or commercially available sterile buffers (such as PBS, pH 7.4) depending on the intended assay environment.
3. Addition of Solvent: Gently introduce the solvent down the inner glass wall of the vial. Avoid direct high-pressure stream injection onto the lyophilized cake.
4. Dissolution: Gently swirl or roll the vial between hands. Never vortex lyophilized proteins, as violent mechanical agitation causes shear stress and irreversible protein denaturation.
Lyophilized Follistatin peptides exhibit superior stability when stored under controlled conditions. Upon arrival at your research facility, unopened vials should be stored in a freezer at -20°C or -80°C, protected from direct light exposure. Under these desiccated conditions, the compound remains stable for up to 24 months.
Once reconstituted into aqueous liquid form, the peptide solution becomes significantly more susceptible to enzymatic degradation and surface adsorption. Reconstituted stock solutions should be divided into single-use aliquots using low-binding microcentrifuge tubes to prevent repeated freeze-thaw cycles. Aliquots stored at 4°C are stable for short-term handling (up to 7 days), while long-term storage of reconstituted aliquots requires -80°C.
PX1 Research is dedicated to supporting academic institutions, biotechnology enterprises, and clinical research organizations with premium research reagents. Facilities looking to secure large-scale batches or arrange recurring supply contracts can coordinate through our wholesale laboratory portal.
All products ship directly from our domestic distribution hubs located in California and Arizona. Same-day shipping is provided for orders placed Monday through Friday before cut-off times, ensuring your laboratory operations maintain momentum without supply chain interruptions. Every shipment includes comprehensive documentation confirming purity, identity, and compliance with strict US manufacturing standards.
What is the primary objective when seeking to bestellen follistatine peptide for laboratory use?
Researchers obtain Follistatin to conduct in vitro and preclinical studies examining TGF-β superfamily signaling, activin binding kinetics, myostatin inhibition, and satellite cell proliferation in muscular tissue models.
What analytical purity standards does PX1 Research guarantee for Follistatin?
Every lot of Follistatin undergoes rigorous RP-HPLC and ESI-MS analysis at an independent ISO 17025 accredited laboratory, guaranteeing a minimum purity of 98% along with precise mass verification.
Why is endotoxin testing critical when ordering Follistatin peptides?
Endotoxins (lipopolysaccharides) introduce unwanted inflammatory responses in cell culture assays and animal models. PX1 Research tests all lots via LAL assays to ensure endotoxin levels remain below 0.01 EU/mg.
How does Follistatin inhibit myostatin in preclinical research models?
Follistatin acts as a soluble binding protein that directly sequesters myostatin (GDF-8) and activin A, preventing these ligands from binding to ActRIIB receptors and suppressing downstream Smad2/3 signaling.
What solvents are recommended for reconstituting lyophilized Follistatin?
For standard laboratory assays, sterile bacteriostatic water, sterile 0.9% saline, or sterile phosphate-buffered saline (PBS, pH 7.4) are recommended depending on the specific requirements of the experimental protocol.
How should reconstituted Follistatin solutions be stored?
Reconstituted solutions should be divided into single-use aliquots to avoid freeze-thaw cycles. Short-term storage (up to 7 days) can be maintained at 4°C, while long-term storage requires -80°C.
Can PX1 Research fulfill bulk institutional orders for research facilities?
Yes. Qualified research institutions and laboratories can place bulk orders and set up recurring procurement through our wholesale program, which includes full COA access and dedicated account support.
Where are PX1 Research peptides manufactured and shipped from?
All PX1 Research compounds are manufactured in US-based, GMP-compliant facilities and shipped directly from our primary fulfillment centers in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.